FilingSEC EDGAR8-K
SCYNEXIS Awarded BARDA Contract for Up to $214 Million
· SEC accepted
StageContract Award
Filing content
The company secured a contract with BARDA providing up to $214 million in non-dilutive funding to support the development of its antifungal candidate, SCY-247, through Phase 2 and NDA submission.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…